Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Childhood and adult height, and early immune-related hospitalizations increase testicular cancer risk, while baldness, larger families, and sports reduce it.

The C-CAT tool helps assess and improve treatment for central centrifugal cicatricial alopecia.

rwSALT provides precise hair regrowth measurement from scalp photos.

The conclusion suggests that a new system for measuring hair loss could be created using automated analysis of photographs.

VESALT improves alopecia areata assessment by including non-scalp areas and is reliable and user-friendly.

The study developed a 3D model that closely imitates remaining ovarian cancer after treatment and identified a potential drug targeting resistant cancer cells.

Some side effects of breast cancer chemotherapy last longer than others, and patient feedback can help improve care.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Trichoscopy effectively differentiates Androgenetic Alopecia from Telogen Effluvium.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

SMR-2 and SMR-6 are much more toxic than retinoic acid, causing severe symptoms and organ damage in mice.

Standardized assessment tools for androgenetic alopecia are needed.

Sentinel lymph node mapping is safe and effective for early-stage ovarian cancer but isn't yet standard practice.

Early detection of chemotherapy side effects allows treatment adjustments, improving patient outcomes.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Higher PSA levels can indicate prostate cancer, but there's overlap with non-cancerous conditions.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Further research is needed to develop effective cancer prevention strategies.

New scale reliably assesses male hair loss with female pattern.

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

The treatment was effective and tolerable for advanced gastric cancer.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

The study found that analyzing certain cell signaling pathways is not a reliable method to tell apart two types of skin tumors.